Prof. Ulrika Simonsson, Ph.D.

Scientific Advisor

Portrait-of-Ulrika-Simonsson_Pharmetheus

Bio

  • Co-founded Pharmetheus in 2012, advising in client projects
  • Expertise includes drug development using model informed drug development, quantitative system pharmacology and machine learning, with extensive experience in regulatory interactions and clinical pharmacology across different therapeutic areas
  • Previously, she worked as Senior Research Scientist at AstraZeneca R&D Sweden, where she conducted pharmacometric analysis and supported trial design, and as Postdoctoral Researcher and Consultant at Pharsight Corporation, CA, USA where she interacted with clients and provided pharmacometric support in client projects. Experience as Professor of Pharmacokinetics at Uppsala University, Sweden
  • M.Sc. in Pharmaceutical Sciences (1995) and Ph.D. in Pharmaceutical Biosciences (2000) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Exposure-Overall Survival Analysis for Quizartinib in Newly Diagnosed Patients with FMS- Like Tyrosine Kinase 3-Internal-Tandem-Duplication-Positive Acute Myeloid Leukemia